Market Closed -
Nasdaq
04:00:00 2025-02-06 pm EST
5-day change
1st Jan Change
122.80 USD
-1.51%
-7.68%
-8.10%
Illumina Starts Pilot Program With Partners to Generate Proteomics Data
January 13, 2025 at 04:44 am EST
This article is reserved for members
Not a member ?
Free registration
Analysts recommendations: Aj Bell, GSK, Anglo American, Eli Lilly, Expedia…
05:34am
Analysts recommendations: Air Products & Chemicals, AMD, Elf Beauty, Eli Lilly, Expedia…
05:18am
Illumina Q4 Non-GAAP Earnings Rise, Revenue Falls; 2025 Outlook Set; Shares Drop After Hours
Feb. 06
MT
Illumina forecasts 2025 revenue largely below estimates
Feb. 06
RE
Illumina, Inc., Q4 2024 Earnings Call, Feb 06, 2025
Feb. 06
Earnings Flash (ILMN) ILLUMINA INC. Posts Q4 Revenue $1.10B, vs. FactSet Est of $1.09B
Feb. 06
MT
Earnings Flash (ILMN) ILLUMINA INC. Posts Q4 Adjusted EPS $0.95, vs. FactSet Est of $0.91
Feb. 06
MT
Illumina, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 29, 2024
Feb. 06
CI
China considers probe into Apple's App Store fees, practices, Bloomberg News reports
Feb. 05
RE
Wall Street rises on US-China trade optimism, energy boost
Feb. 04
RE
Wall Street gains on US-China trade optimism, energy boost
Feb. 04
RE
PVH, Illumina Added to China's Unreliable Companies List by Ministry
Feb. 04
MT
S&P 500 gains on energy boost; Trump-Xi talks in focus
Feb. 04
RE
Top Midday Stories: China Retaliates With Tariffs, Antitrust Probe of Google; Merck Shares Tumble on Downbeat Guidance
Feb. 04
MT
S&P 500, Nasdaq rise as megacaps charge ahead; tariffs in focus
Feb. 04
RE
Illumina, PVH shares drop as China threatens companies with sanctions
Feb. 04
RE
Shares of Calvin Klein-parent PVH and Illumina fall after China targets companies
Feb. 04
RE
Wall St set for subdued open after China's retaliatory tariffs
Feb. 04
RE
Futures muted as China imposes retaliatory tariffs
Feb. 04
RE
RBC Trims Price Target on Illumina to $250 From $252, Keeps Outperform Rating
Feb. 04
MT
Futures tick lower as China responds to US tariffs
Feb. 04
RE
China Retaliates With Tariffs on US Goods, Google Antitrust Probe Amid Trade Tensions
Feb. 04
MT
WRAPUP 8-China launches limited tariffs after Trump imposes sweeping new levies
Feb. 04
RE
PVH, Illumina Added to China's Unreliable Companies List
Feb. 04
MT
Diageo makes tariff contingency; Vodafone backs guide
Feb. 04
AN
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
ILMN: Dynamic Chart
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows:
- product sales (84.1%): tools and instruments for sequencing, genotyping, genetic expression, etc.;
- sales of services (15.9%).
Net sales are distributed geographically as follows: the United States (52.4%), Americas (3.6%), Europe (25.3%), Asia/Pacific/Middle East/Africa (10.2%) and China/Taiwan/Hong Kong (8.5%).
More about the company
Last Close Price
122.80 USD
Average target price
155.17 USD
Spread / Average Target
+26.36%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1